OTTAWA - A commander of a patrol frigate in the Royal Canadian Navy has been relieved of his duty mid-deployment due to what ...

Q4 2024 Earnings Call Transcript February 6, 2025 Neurocrine Biosciences, Inc. misses on earnings expectations. Reported EPS ...

The rapper has mastered the delicate balance between commercial success and politically charged music. How far will he push ...

Cardinal Health (NYSE:CAH – Get Free Report) had its price target upped by equities researchers at Wells Fargo & Company from ...

Shares of Cardinal Health Inc. CAH advanced 1.82% to $127.45 Wednesday, on what proved to be an all-around great trading ...

Jefferies analyst Brian Tanquilut upgraded Cardinal Health (CAH) to Buy from Hold with a price target of $150, up from $140. The firm thinks ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cardinal Health (CAH – Research Report) and Apyx ...

Neurocrine's pipeline includes 12 clinical programs, with two Phase 3 trials due to report in 2025. See why I rate NBIX stock ...

VICTORIA - Canada's chief justice said he wanted to "bring the Supreme Court closer to Canadians" at a time of increasing ...

Cardinal Health’s acquisition of Advanced Diabetes Supply Group hasn’t closed yet, but company officials said on a conference call to discuss second quarter financial results that ...

Jan 30 (Reuters) - Drug distributor Cardinal Health on Thursday raised its fiscal 2025 adjusted profit forecast as strong ...

Drug distributor Cardinal Health said on Thursday it may need to increase prices of some of its products if the proposed tariffs on Mexico go into effect, to counter increasing costs of manufacturing ...